Introduction
Octreotide acetate is a synthetic analog of somatostatin, a naturally occurring peptide hormone. It is used in the treatment of various endocrine disorders and some cancers. By mimicking the effects of somatostatin, octreotide helps regulate hormone secretion and manage symptoms associated with excessive hormone production.
Uses
Octreotide acetate is used for:
- Managing acromegaly (a condition characterized by excessive growth hormone production).
- Treating symptoms of neuroendocrine tumors, including carcinoid tumors and VIPomas (vasoactive intestinal peptide secreting tumors).
- Controlling severe diarrhea and flushing episodes associated with carcinoid syndrome.
- Managing complications of pancreatic cancer, such as pancreatic fistulas and severe diarrhea.
- Reducing bleeding risk in patients with esophageal varices due to portal hypertension.
| Brand Name | Octreotide |
|---|---|
| Type | Injection |
| Weight | 100 mcg/ml |
| Generic | Octreotide Acetate |
| Manufacturer | Sun Pharmaceutical (Bangladesh) Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Octreotide acetate works by:
- Somatostatin Analog: Mimicking the actions of somatostatin, which inhibits the secretion of growth hormone, insulin, glucagon, and other hormones.
- Regulating Hormone Secretion: Reducing the levels of hormones produced by tumors or overactive endocrine glands.
- Reducing Tumor Blood Flow: Decreasing blood flow to tumors, which may help slow their growth.
How Long Does It Take to Work?
The onset of action for octreotide acetate can vary depending on the condition being treated. For symptom relief from neuroendocrine tumors and acromegaly, improvements may be observed within a few days to weeks of initiating treatment. The therapeutic effect and optimal dose are usually assessed and adjusted based on individual patient response.
Absorption
Octreotide acetate is administered either subcutaneously (SC) or intravenously (IV). When given subcutaneously, it is well-absorbed with peak plasma concentrations typically reached within 30 minutes to 2 hours. Intravenous administration provides rapid absorption and is used in acute settings.
Route of Elimination
Octreotide acetate is primarily eliminated through:
- Renal Elimination: Approximately 30-50% of the drug is excreted unchanged in the urine.
- Metabolism: The drug is metabolized in the liver and kidneys.
Dosage
Dosage of octreotide acetate varies based on the condition being treated:
- Acromegaly: Initial dose of 50-100 mcg subcutaneously 2-3 times daily, adjusted based on clinical response.
- Neuroendocrine Tumors: Typically 100-200 mcg subcutaneously 2-3 times daily.
- VIPoma: Initial dose of 200 mcg subcutaneously 3 times daily, titrated based on symptoms.
- Esophageal Variceal Bleeding: 50 mcg IV bolus every 1-2 hours for up to 5 days.
Administration
Octreotide acetate is administered either subcutaneously or intravenously, depending on the clinical setting and the condition being treated. Subcutaneous injections are typically given in the thigh, abdomen, or upper arm. For intravenous use, it is administered by infusion or bolus injection as directed by a healthcare provider.
Side Effects
Common side effects of octreotide acetate include:
- Gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain.
- Injection site reactions including pain, redness, or swelling.
- Headache, dizziness, and fatigue.
- Gallbladder issues such as gallstones.
- Hypoglycemia or hyperglycemia.
- Bradycardia or arrhythmias.
Toxicity
Toxicity from octreotide acetate is rare but may occur with overdose or sensitivity. Symptoms of toxicity may include severe gastrointestinal distress, significant changes in blood glucose levels, or severe bradycardia. Immediate medical attention is necessary in case of suspected overdose or severe reactions.
Precautions
Precautions for using octreotide acetate include:
- Monitoring for gastrointestinal disturbances and gallbladder function.
- Adjusting dosage in patients with renal or hepatic impairment.
- Careful use in patients with diabetes due to potential effects on blood glucose levels.
Interaction
Potential drug interactions include:
- Antidiabetic Medications: Octreotide can affect blood glucose levels, potentially requiring adjustments in antidiabetic therapy.
- Cardiovascular Drugs: Caution with drugs affecting heart rate or blood pressure, as octreotide may cause bradycardia or other cardiac effects.
Disease Interaction
Use octreotide acetate with caution in:
- Diabetes Mellitus: Due to potential impacts on blood glucose levels.
- Renal Impairment: Adjust dosage as needed and monitor renal function.
- Hepatic Impairment: Dose adjustments may be necessary based on liver function.
Drug Interaction
Potential drug interactions include:
- Insulin and Oral Hypoglycemics: Monitor blood glucose levels closely as octreotide can affect glucose metabolism.
- Calcium Channel Blockers: Increased risk of bradycardia; monitor heart rate and rhythm.
Food Interactions
No significant food interactions are known with octreotide acetate. However, monitoring for any gastrointestinal symptoms or changes in blood glucose levels is advised, as they may be influenced by dietary factors.
Pregnancy Use
Octreotide acetate should be used during pregnancy only if the potential benefits outweigh the risks. Limited data are available on its use during pregnancy. Consult with a healthcare provider to evaluate the risks and benefits before use in pregnant women.
Lactation Use
It is not known whether octreotide acetate is excreted in breast milk. Use during lactation should be approached with caution. Consult with a healthcare provider to assess the potential risks to the infant and the need for alternative treatments.
Acute Overdose
In case of acute overdose, symptoms may include severe gastrointestinal distress, significant changes in blood glucose levels, or severe bradycardia. Immediate medical intervention is necessary to manage overdose symptoms and provide appropriate treatment.
Contraindication
Contraindications include:
- Hypersensitivity to octreotide acetate or any of its components.
- Certain endocrine tumors or conditions where octreotide use may be inappropriate or potentially harmful.
Use Direction
Use octreotide acetate as directed by a healthcare provider. For subcutaneous administration, follow the prescribed dosage and injection technique. For intravenous use, follow specific instructions for infusion or bolus administration. Regular monitoring and follow-up with a healthcare provider are important to adjust the dose and manage treatment.
Storage Conditions
Store octreotide acetate at 2-8°C (36-46°F). Do not freeze. Keep it in its original packaging and out of reach of children. Ensure proper storage conditions to maintain the efficacy and safety of the medication.
Volume of Distribution
The volume of distribution for octreotide acetate is approximately 0.2 L/kg. This indicates the extent to which the drug distributes into body tissues compared to plasma volume. The volume of distribution can vary based on individual patient characteristics and conditions.
Half Life
The half-life of octreotide acetate is approximately 1.5 to 2.5 hours after intravenous administration. For the subcutaneous form, the half-life may be slightly longer, allowing for less frequent dosing in some patients.
Clearance
Octreotide acetate is cleared primarily through renal excretion and hepatic metabolism. The clearance rate is affected by renal and liver function, with approximately 30-50% of the drug excreted unchanged in the urine. Clearance can vary based on individual patient characteristics and health conditions.
See in details version Octreotide Injection 100 mcg/ml also Octreotide Injection 100 mcg/ml in bangla
Social card
Some Frequently Asked Questions About Octreotide Injection 100 mcg/ml
